Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sight Sciences (SGHT) Free Cash Flow (2020 - 2025)

Sight Sciences (SGHT) has 6 years of Free Cash Flow data on record, last reported at -$1.7 million in Q4 2025.

  • For Q4 2025, Free Cash Flow rose 53.53% year-over-year to -$1.7 million; the TTM value through Dec 2025 reached -$29.9 million, down 31.59%, while the annual FY2025 figure was -$29.9 million, 31.59% down from the prior year.
  • Free Cash Flow reached -$1.7 million in Q4 2025 per SGHT's latest filing, up from -$8.9 million in the prior quarter.
  • Across five years, Free Cash Flow topped out at $311000.0 in Q3 2024 and bottomed at -$22.2 million in Q1 2022.
  • Average Free Cash Flow over 5 years is -$11.5 million, with a median of -$11.2 million recorded in 2021.
  • Peak YoY movement for Free Cash Flow: soared 103.07% in 2024, then plummeted 2958.2% in 2025.
  • A 5-year view of Free Cash Flow shows it stood at -$10.9 million in 2021, then crashed by 43.68% to -$15.6 million in 2022, then skyrocketed by 56.83% to -$6.7 million in 2023, then soared by 46.71% to -$3.6 million in 2024, then surged by 53.53% to -$1.7 million in 2025.
  • Per Business Quant database, its latest 3 readings for Free Cash Flow were -$1.7 million in Q4 2025, -$8.9 million in Q3 2025, and -$7.8 million in Q2 2025.